Gilead Named Number One Overall Philanthropic Funder of HIV-Related Programs for Second Year in a Row by Funders Concerned About AIDS
Gilead Sciences, Inc. (Nasdaq: GILD) today was recognized as the number one philanthropic funder of HIV-related programs for the second year in a row, in a new report released by Funders Concerned About AIDS (FCAA).
- Gilead Sciences, Inc. (Nasdaq: GILD) today was recognized as the number one philanthropic funder of HIV-related programs for the second year in a row, in a new report released by Funders Concerned About AIDS (FCAA).
- “We know that progress against HIV depends on more than scientific innovation, which is why we support the community organizations doing remarkable work to eliminate barriers to care.
- “This support is more essential than ever given the incredibly challenging environment in which we find ourselves.
- Initiative – a 3-year, $10 million commitment to increase HIV prevention, anti-stigma and health equity efforts for Black cisgender and Transgender women and girls in the United States.